The past, present and future of fertility preservation in cancer patients (Q38965305)

8 September 2017

The past, present and future of fertility preservation in cancer patients (English)

1 reference

8 September 2017

Charlotte Sonigo

1

1 reference

8 September 2017

Nathalie Sermondade

2

1 reference

8 September 2017

Julie Benard

3

1 reference

8 September 2017

Alexandra Benoit

4

1 reference

8 September 2017

Joanna Shore

5

1 reference

8 September 2017

Christophe Sifer

6

1 reference

8 September 2017

Michael Grynberg

7

1 reference

8 September 2017

language of work or name

English

0 references

publication date

11 September 2015

1 reference

8 September 2017

1 reference

8 September 2017

Cancer statistics, 2015

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Pretreatment semen parameters in men with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Fertility preservation for young patients with cancer: who is at risk and what can be offered?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Fertility preservation in men with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Concerns about infertility risks among pediatric oncology patients and their parents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Sperm DNA damage and cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Clinical guidelines for sperm cryopreservation in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Sperm cryopreservation before cancer treatment: a 15-year monocentric experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Techniques for cryopreservation of individual or small numbers of human spermatozoa: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Successful use of the Cryolock device for cryopreservation of scarce human ejaculate and testicular spermatozoa.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Sperm cryopreservation in adolescents and young adults with cancer: results of the French national sperm banking network (CECOS)

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Clinical and biochemical correlates of successful semen collection for cryopreservation from 12-18-year-old patients: a single-center study of 86 adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Electroejaculation as a method of fertility preservation in boys diagnosed with cancer: a single-center experience and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Spermatogonial stem cell preservation and transplantation: from research to clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Germline development from human pluripotent stem cells toward disease modeling of infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Vitrification preserves proliferation capacity in human spermatogonia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Spermatogonial survival in long-term human prepubertal xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Birth of offspring following transplantation of cryopreserved immature testicular pieces and in-vitro microinsemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Spermatogenesis following male germ-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Reproductive capacity of sperm obtained after germ cell transplantation in a mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Spermatogonial stem cell transplantation into rhesus testes regenerates spermatogenesis producing functional sperm.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Cell selection by selective matrix adhesion is not sufficiently efficient for complete malignant cell depletion from contaminated human testicular cell suspensions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

In vitro production of functional sperm in cultured neonatal mouse testes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Concise review: Spermatogenesis in an artificial three-dimensional system

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

SOX17 is a critical specifier of human primordial germ cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Ovarian tissue cryopreservation and transplantation: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Toxicity of chemotherapy and radiation on female reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Antimüllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

The mammalian ovary from genesis to revelation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Gonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network FertiPROTEKT.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Oncofertility in Canada: gonadal protection and fertility-sparing strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Obstetric and perinatal outcome of babies born from vitrified oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Clinical outcomes following cryopreservation of blastocysts by vitrification or slow freezing: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Slow freezing, vitrification and ultra-rapid freezing of human embryos: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Mature oocyte cryopreservation: a guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Age-specific probability of live birth with oocyte cryopreservation: an individual patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Healthy twins delivered after oocyte cryopreservation and bilateral ovariectomy for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Live birth with vitrified-warmed oocytes of a chronic myeloid leukemia patient nine years after allogenic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Live birth using vitrified--warmed oocytes in invasive ovarian cancer: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Live birth after 6 years of oocyte vitrification in a survivor with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Twins born after transplantation of ovarian cortical tissue and oocyte vitrification

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Luteal phase oocyte retrieval and in vitro maturation is an optional procedure for urgent fertility preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

In vitro maturation of oocytes: uncommon indications

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Vitrification of in vitro matured oocytes collected from antral follicles at the time of ovarian tissue cryopreservation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

First pregnancy and live birth resulting from cryopreserved embryos obtained from in vitro matured oocytes after oophorectomy in an ovarian cancer patient

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

In vitro maturation of oocytes is not associated with altered deoxyribonucleic acid methylation patterns in children from in vitro fertilization or intracytoplasmic sperm injection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Exogenous growth differentiation factor 9 in oocyte maturation media enhances subsequent embryo development and fetal viability in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Simulated physiological oocyte maturation (SPOM): a novel in vitro maturation system that substantially improves embryo yield and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Fertility preservation in women with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Fertility in cancer patients after cryopreservation of one ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Transplantation of ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Assessment of long term endocrine function after transplantation of frozen-thawed human ovarian tissue to the heterotopic site: 10 year longitudinal follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Successful vitrification and autografting of baboon (Papio anubis) ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Improving ovarian tissue cryopreservation for oncologic patients: slow freezing versus vitrification, effect of different procedures and devices

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Fertility preservation in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Minimal residual disease detection in cryopreserved ovarian tissue by multicolor flow cytometry in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

First step in developing a 3D biodegradable fibrin scaffold for an artificial ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

A new step toward the artificial ovary: survival and proliferation of isolated murine follicles after autologous transplantation in a fibrin scaffold.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Development in vitro of mouse oocytes from primordial follicles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their developmental competence.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Ovarian follicle culture: advances and challenges for human and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

The immature human ovary shows loss of abnormal follicles and increasing follicle developmental competence through childhood and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Germline stem cells and follicular renewal in the postnatal mammalian ovary

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Offspring from Oocytes Derived from in Vitro Primordial Germ Cell-like Cells in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Ovarian stem cells--potential roles in infertility treatment and fertility preservation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Livebirth after uterus transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

First clinical uterus transplantation trial: a six-month report

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Does sphingosine-1-phosphate have a protective effect on cyclophosphamide- and irradiation-induced ovarian damage in the rat model?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

In vivo delivery of FTY720 prevents radiation-induced ovarian failure and infertility in adult female nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Thalidomide treatment attenuates chemotherapy-induced gonadal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Insights into the protective mechanisms of tamoxifen in radiotherapy-induced ovarian follicular loss: impact on insulin-like growth factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Fertility preservation in cancer patients: the global framework

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Fertilizing Capacity of Frozen Human Spermatozoa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Can pubertal boys with Klinefelter syndrome benefit from spermatogonial stem cell banking?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

Towards the development of a bioengineered uterus: Comparison of different protocols for rat uterus decellularization

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.152

21 January 2018

Identifiers

0 references

1 reference